April 19 (Reuters) - Papilly AB PAPI.ST :
* SAID ON FRIDAY CO ENTERS LETTER OF INTENT REGARDING
ACQUISITION
OF BONZUN HEALTH INFORMATION AB THROUGH DIRECTED ISSUE IN KIND
* NON-BINDING LOI WITH OWNERS OF ABOUT 60% OF SHARES IN
BONZUN
REGARDING ACQUISITION OF ALL SHARES IN BONZUN THROUGH ISSUE IN
KIND
* PAPILLY INTENDS IN CONNECTION WITH THE TRANSACTION TO
CHANGE
NAME TO BONZUN AB (PUBL)
* TO ACQUIRE ALL SHARES IN BONZUN THROUGH DIRECTED ISSUE IN
KIND
OF 1,099,086,469 NEW SHARES IN CO, WHICH REPRESENTS 65% OF
SHARES IN PAPILLY AFTER TRANSACTION
* SUBSCRIPTION PRICE TO AMOUNT TO ABOUT SEK 0.10 PER SHARE
* IN TRANSACTION BONZUN IS VALUED AT SEK 110 MLN AND PAPILLY
AT
ABOUT SEK 60 MLN
* INTENTION IS THAT PAPILLY'S SHARES ARE STILL LISTED ON
NASDAQ
FIRST NORTH GROWTH MARKET AFTER TRANSACTION
* LOI IS VALID UNTIL MAY 31, 2021 AND THEN EXPIRES IF NO
FINAL
TRANSFER AGREEMENT IS ENTERED BETWEEN THE PARTIES
Source text for Eikon: urn:newsml:reuters.com:*:nBQNj5rc
Further company coverage: PAPI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00))